GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
Global alliance in biomolecular imaging
GE Healthcare, a unit of General Electric Company, announced that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare. The products will be sold worldwide under the GE brand in the life science research and drug discovery markets.
Life science research has advanced rapidly in recent years with the advent of tools for genomic and protein research such as biomolecular labeling, detection and analysis. These technologies have helped reveal the functions of proteins, thereby contributing to scientists’ understanding of disease processes. The use of life science instrumentation and reagents in bioscience research is growing, and the demand for new and innovative enabling technologies is expanding.
Overview of the alliance:
1. Fujifilm will supply image analyzing systems for bioscience research to GE Healthcare, and GE Healthcare will market and sell them under the GE brand.
2. GE Healthcare will be responsible for marketing/sales of the systems worldwide, and will provide total solutions including instruments, ECL and DIGE labeling reagents, and applications support. Additionally, GE Healthcare will provide instrument services for the systems.
3. Fujifilm and GE Healthcare will collaborate to develop image analyzing systems that are optimized for customer applications.
Other news from the department business & finance
These products might interest you
Amersham ImageQuant™ 800 Western blot imaging systems by Cytiva
Amersham ImageQuant 800 Western blot imaging systems
Flexible imagers with automated features
Amersham Typhoon™ biomolecular imager by Cytiva
Typhoon biomolecular imager
Imaging for northern and southern blots and imaging of large electrophoresis gels and tissues
